Global Poloxamer 338 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Get Access Now!

Global Poloxamer 338 Market Growth (Status and Outlook) 2025-2031

The global Poloxamer 338 market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Poloxamer 338 is polymers made of a block of polyoxyethylene, followed by a block of polyoxypropylene, followed by a block of polyoxyethylene. The average number of units of polyoxyethylene and polyoxypropylene varies based on the number associated with thepolymerA naturally occurring or synthetic molecule made up of repeating units called monomers.. For example, the smallest polymer, Poloxamer 101, consists of a block with an average of 2 units of polyoxyethylene, a block with an average of 16 units of polyoxypropylene, followed by a block with an average of 2 units of polyoxyethylene. Poloxamers range from colorless liquids and pastes to white solids. In cosmetics and personal care products, Poloxamers are used in the formulation of skin cleansers, bath products, shampoos, hair conditioners, mouthwashes, eye makeup remover and other skin and hair products. United States market for Poloxamer 338 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. China market for Poloxamer 338 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Europe market for Poloxamer 338 is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031. Global key Poloxamer 338 players cover BASF, Croda, CD Formulation, Comercial Qumica Mass, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024. Infinity Market Research newest research report, the Poloxamer 338 Industry Forecast looks at past sales and reviews total world Poloxamer 338 sales in 2024, providing a comprehensive analysis by region and market sector of projected Poloxamer 338 sales for 2025 through 2031. With Poloxamer 338 sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Poloxamer 338 industry. This Insight Report provides a comprehensive analysis of the global Poloxamer 338 landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Poloxamer 338 portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Poloxamer 338 market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Poloxamer 338 and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Poloxamer 338. This report presents a comprehensive overview, market shares, and growth opportunities of Poloxamer 338 market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Purity 99% &nbsp;&nbsp;&nbsp; Purity 99.9% &nbsp;&nbsp;&nbsp; Others Segmentation by Application: &nbsp;&nbsp;&nbsp; Cosmetic &nbsp;&nbsp;&nbsp; Pharmaceuticals &nbsp;&nbsp;&nbsp; Others This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; BASF &nbsp;&nbsp;&nbsp; Croda &nbsp;&nbsp;&nbsp; CD Formulation &nbsp;&nbsp;&nbsp; Comercial Qumica Mass Key Questions Addressed in this Report What is the 10-year outlook for the global Poloxamer 338 market? What factors are driving Poloxamer 338 market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Poloxamer 338 market opportunities vary by end market size? How does Poloxamer 338 break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Poloxamer 338 Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Poloxamer 338 by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Poloxamer 338 by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Poloxamer 338 Segment by Type &nbsp;2.2.1 Purity 99% &nbsp;2.2.2 Purity 99.9% &nbsp;2.2.3 Others &nbsp;2.3 Poloxamer 338 Sales by Type &nbsp;2.3.1 Global Poloxamer 338 Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Poloxamer 338 Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Poloxamer 338 Sale Price by Type (2020-2025) &nbsp;2.4 Poloxamer 338 Segment by Application &nbsp;2.4.1 Cosmetic &nbsp;2.4.2 Pharmaceuticals &nbsp;2.4.3 Others &nbsp;2.5 Poloxamer 338 Sales by Application &nbsp;2.5.1 Global Poloxamer 338 Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Poloxamer 338 Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Poloxamer 338 Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Poloxamer 338 Breakdown Data by Company &nbsp;3.1.1 Global Poloxamer 338 Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Poloxamer 338 Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Poloxamer 338 Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Poloxamer 338 Revenue by Company (2020-2025) &nbsp;3.2.2 Global Poloxamer 338 Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Poloxamer 338 Sale Price by Company &nbsp;3.4 Key Manufacturers Poloxamer 338 Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Poloxamer 338 Product Location Distribution &nbsp;3.4.2 Players Poloxamer 338 Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Poloxamer 338 by Geographic Region &nbsp;4.1 World Historic Poloxamer 338 Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Poloxamer 338 Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Poloxamer 338 Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Poloxamer 338 Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Poloxamer 338 Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Poloxamer 338 Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Poloxamer 338 Sales Growth &nbsp;4.4 APAC Poloxamer 338 Sales Growth &nbsp;4.5 Europe Poloxamer 338 Sales Growth &nbsp;4.6 Middle East & Africa Poloxamer 338 Sales Growth 5 Americas &nbsp;5.1 Americas Poloxamer 338 Sales by Country &nbsp;5.1.1 Americas Poloxamer 338 Sales by Country (2020-2025) &nbsp;5.1.2 Americas Poloxamer 338 Revenue by Country (2020-2025) &nbsp;5.2 Americas Poloxamer 338 Sales by Type (2020-2025) &nbsp;5.3 Americas Poloxamer 338 Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Poloxamer 338 Sales by Region &nbsp;6.1.1 APAC Poloxamer 338 Sales by Region (2020-2025) &nbsp;6.1.2 APAC Poloxamer 338 Revenue by Region (2020-2025) &nbsp;6.2 APAC Poloxamer 338 Sales by Type (2020-2025) &nbsp;6.3 APAC Poloxamer 338 Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Poloxamer 338 by Country &nbsp;7.1.1 Europe Poloxamer 338 Sales by Country (2020-2025) &nbsp;7.1.2 Europe Poloxamer 338 Revenue by Country (2020-2025) &nbsp;7.2 Europe Poloxamer 338 Sales by Type (2020-2025) &nbsp;7.3 Europe Poloxamer 338 Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Poloxamer 338 by Country &nbsp;8.1.1 Middle East & Africa Poloxamer 338 Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Poloxamer 338 Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Poloxamer 338 Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Poloxamer 338 Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Poloxamer 338 &nbsp;10.3 Manufacturing Process Analysis of Poloxamer 338 &nbsp;10.4 Industry Chain Structure of Poloxamer 338 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Poloxamer 338 Distributors &nbsp;11.3 Poloxamer 338 Customer 12 World Forecast Review for Poloxamer 338 by Geographic Region &nbsp;12.1 Global Poloxamer 338 Market Size Forecast by Region &nbsp;12.1.1 Global Poloxamer 338 Forecast by Region (2026-2031) &nbsp;12.1.2 Global Poloxamer 338 Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Poloxamer 338 Forecast by Type (2026-2031) &nbsp;12.7 Global Poloxamer 338 Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 BASF &nbsp;13.1.1 BASF Company Information &nbsp;13.1.2 BASF Poloxamer 338 Product Portfolios and Specifications &nbsp;13.1.3 BASF Poloxamer 338 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 BASF Main Business Overview &nbsp;13.1.5 BASF Latest Developments &nbsp;13.2 Croda &nbsp;13.2.1 Croda Company Information &nbsp;13.2.2 Croda Poloxamer 338 Product Portfolios and Specifications &nbsp;13.2.3 Croda Poloxamer 338 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 Croda Main Business Overview &nbsp;13.2.5 Croda Latest Developments &nbsp;13.3 CD Formulation &nbsp;13.3.1 CD Formulation Company Information &nbsp;13.3.2 CD Formulation Poloxamer 338 Product Portfolios and Specifications &nbsp;13.3.3 CD Formulation Poloxamer 338 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 CD Formulation Main Business Overview &nbsp;13.3.5 CD Formulation Latest Developments &nbsp;13.4 Comercial Qu�mica Mass� &nbsp;13.4.1 Comercial Qu�mica Mass� Company Information &nbsp;13.4.2 Comercial Qu�mica Mass� Poloxamer 338 Product Portfolios and Specifications &nbsp;13.4.3 Comercial Qu�mica Mass� Poloxamer 338 Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Comercial Qu�mica Mass� Main Business Overview &nbsp;13.4.5 Comercial Qu�mica Mass� Latest Developments 14 Research Findings and Conclusion

Report	Global Poloxamer 338 Market Growth 2025-2031
Selected License	Multi ID: LPI32726

Buyer Information

Order Summary